References
1. Hoy RF, Jeebhay MF,
Cavalin C, et al. Current global perspectives on silicosis—Convergence
of old and newly emergent hazards. Respirology.
2022;27(6):387-398. doi:10.1111/resp.14242
2. Global burden of
369 diseases and injuries in 204 countries and territories, 1990–2019:
a systematic analysis for the Global Burden of Disease Study 2019.Lancet. 2020;396(10258):1204-1222.
doi:10.1016/S0140-6736(20)30925-9
3. Fernández Álvarez
R, Martínez González C, Quero Martínez A, Blanco Pérez JJ, Carazo
Fernández L, Prieto Fernández A. Guidelines for the diagnosis and
monitoring of silicosis. Arch Bronconeumol. 2015;51(2):86-93.
doi:10.1016/j.arbres.2014.07.010
4. Rupani MP. A
mixed-methods study on impact of silicosis on tuberculosis treatment
outcomes and need for TB-silicosis collaborative activities in India.Sci Rep. 2023;13(1):2785. doi:10.1038/s41598-023-30012-4
5. Chen FF, Tang HY,
Yu F, et al. Renal involvement in a silicosis patient – case report and
literature review. Ren Fail. 2019;41(1):1045-1053.
doi:10.1080/0886022X.2019.1696209
6. Rom WN, Bitterman
PB, Rennard SI, Cantin A, Crystal RG. Characterization of the lower
respiratory tract inflammation of nonsmoking individuals with
interstitial lung disease associated with chronic inhalation of
inorganic dusts. Am Rev Respir Dis. 1987;136(6):1429-1434.
doi:10.1164/ajrccm/136.6.1429
7. Reiser KM, Last JA.
Silicosis and fibrogenesis: fact and artifact. Toxicology.
1979;13(1):51-72.
8. Guarnieri G,
Bizzotto R, Gottardo O, et al. Multiorgan accelerated silicosis
misdiagnosed as sarcoidosis in two workers exposed to quartz
conglomerate dust. Occup Environ Med. 2019;76(3):178-180.
doi:10.1136/oemed-2018-105462
9. Shrestha AB, Yadav
AK, Shrestha S, et al. A rare case of silicosis with hepatitis B
infection. Ann Med Surg (Lond). 2022;84:104838.
doi:10.1016/j.amsu.2022.104838
10. Tavakol E, Azari
M, Zendehdel R, et al. Risk Evaluation of Construction Workers’ Exposure
to Silica Dust and the Possible Lung Function Impairments.Tanaffos. 2017;16(4):295-303.
11. Mohammadi H,
Farhang Dehghan S, Tahamtan A, Golbabaei F. Evaluation of potential
biomarkers of exposure to crystalline silica: A case study in an
insulator manufacturer. Toxicol Ind Health. 2018;34(7):491-498.
doi:10.1177/0748233718770073
12. Hamaguchi Y,
Nishizawa Y, Yasui M, et al. Intercellular Adhesion Molecule-1 and
L-Selectin Regulate Bleomycin-Induced Lung Fibrosis. The American
Journal of Pathology. 2002;161(5):1607-1618.
doi:10.1016/S0002-9440(10)64439-2
13. Tuberculosis.
Accessed July 15, 2023.
https://www.who.int/southeastasia/health-topics/tuberculosis
14. Cowie RL. The
epidemiology of tuberculosis in gold miners with silicosis. Am J
Respir Crit Care Med. 1994;150(5 Pt 1):1460-1462.
doi:10.1164/ajrccm.150.5.7952577
15. Farazi A,
Jabbariasl M. Silico-tuberculosis and associated risk factors in central
province of Iran. Pan Afr Med J. 2015;20:333.
doi:10.11604/pamj.2015.20.333.4993
16. Cao Z jie, Liu Y,
Zhang Z, et al. Pirfenidone ameliorates silica-induced lung inflammation
and fibrosis in mice by inhibiting the secretion of interleukin-17A.Acta Pharmacol Sin. 2022;43(4):908-918.
doi:10.1038/s41401-021-00706-4
17. Wollin L, Maillet
I, Quesniaux V, Holweg A, Ryffel B. Antifibrotic and anti-inflammatory
activity of the tyrosine kinase inhibitor nintedanib in experimental
models of lung fibrosis. J Pharmacol Exp Ther.
2014;349(2):209-220. doi:10.1124/jpet.113.208223
18. Hoy RF, Chambers
DC. Silica-related diseases in the modern world. Allergy.
2020;75(11):2805-2817. doi:10.1111/all.14202